Researchers at the University of California San Francisco have pinpointed a single iron-associated protein called FTL1 as a key driver of age-related cognitive decline. Published in Nature Aging on April 5, the study led by Dr. Saul Villeda found that FTL1 was the only protein consistently elevated in older mice compared to younger ones. Higher levels weakened neural connections in the hippocampus — the brain's learning and memory center — and impaired performance on cognitive tests.
The breakthrough came when the team reduced FTL1 levels in aging mice. Brain connections rebuilt, cellular metabolism in the hippocampus recovered, and memory performance improved significantly. "It is truly a reversal of impairments — much more than merely delaying or preventing symptoms," said Dr. Villeda, Associate Director of UCSF's Bakar Aging Research Institute.
The researchers also found that elevated FTL1 slows cellular energy production, but treating affected cells with a metabolism-boosting compound prevented the damage entirely. This dual mechanism — targeting FTL1 directly or counteracting its metabolic effects — opens two potential therapeutic pathways for treating age-related cognitive decline in humans.
